SEC Form 4 · accession 0001209191-17-039165
CRESCENT BIOPHARMA, INC. · CBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patricia S Andrews
Director
Period of report
Jun 9, 2017
Accepted (ET)
Jun 12, 2017 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001253689
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.63 | Jun 9, 2017 | A | 22,000 | A | — | Jun 9, 2027 | Common Stock | 22,000 | 22,000 | D |
Explanation of responses
- F1This option grant was made pursuant to the issuer's non-employee director compensation policy. The shares underlying this option vest in three equal installments on June 9, 2018, 2019 and 2020, subject to the reporting person's continuous service with the issuer at each vesting date.